share_log

Spero Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Anson Funds Management LP(6.9%),Anson Management GP LLC(6.9%), etc.

Spero Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Anson Funds Management LP(6.9%),Anson Management GP LLC(6.9%)等

美股SEC公告 ·  11/14 17:41
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息